Literature DB >> 17264497

Intraocular diseases - anterior uveitis.

Nalini S Bora1, Henry J Kaplan.   

Abstract

Uveitis is a general term for inflammatory disorders of the uveal tract and encompasses a wide range of underlying etiologies. It may be idiopathic, associated with systemic diseases or result from a variety of infectious agents. Uveitis is responsible for over 2.8% of blindness in the United States. Each year, 17.6% of active uveitis patients experience a transient or permanent loss of vision. Anterior uveitis (AU), which refers to inflammation within the anterior segment of the eye, is the most common form of uveitis. Experimental autoimmune AU (EAAU) is an organ-specific autoimmune disease of the eye, which serves as an animal model of idiopathic human AU. Recently, type I collagen was identified as the target autoantigen in EAAU. Thus, human AU may be an e xample of autoimmunity to local ocular collagen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264497     DOI: 10.1159/000099272

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN: 0079-6034


  10 in total

1.  Tolerance to melanin-associated antigen in autoimmune uveitis is mediated by CD4+CD25+ T-regulatory cells.

Authors:  Bharati Matta; Purushottam Jha; Puran S Bora; Nalini S Bora
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

2.  Inhibitory role of transforming growth factor β2 in experimental autoimmune anterior uveitis.

Authors:  Bharati Matta; Puran S Bora; Adam J Neuhouser; Nalini S Bora
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-02-05       Impact factor: 3.117

3.  Suppression of complement activation by recombinant Crry inhibits experimental autoimmune anterior uveitis (EAAU).

Authors:  Balasubramanian Manickam; Purushottam Jha; Natalie J Hepburn; B Paul Morgan; Claire L Harris; Puran S Bora; Nalini S Bora
Journal:  Mol Immunol       Date:  2010-09-16       Impact factor: 4.407

4.  Inhibition of complement alternative pathway suppresses experimental autoimmune anterior uveitis by modulating T cell responses.

Authors:  Balasubramanian Manickam; Purushottam Jha; Bharati Matta; Juan Liu; Puran S Bora; Nalini S Bora
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

5.  Identification of Hnrph3 as an autoantigen for acute anterior uveitis.

Authors:  Youngbae Kim; Nora B Caberoy; Gabriela Alvarado; Janet L Davis; William J Feuer; Wei Li
Journal:  Clin Immunol       Date:  2010-10-12       Impact factor: 3.969

Review 6.  The role of complement system in ocular diseases including uveitis and macular degeneration.

Authors:  Purushottam Jha; Puran S Bora; Nalini S Bora
Journal:  Mol Immunol       Date:  2007-09       Impact factor: 4.407

7.  Proteolytic cleavage of type I collagen generates an autoantigen in autoimmune uveitis.

Authors:  Purushottam Jha; Balasubramanian Manickam; Bharati Matta; Puran S Bora; Nalini S Bora
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

8.  Effects of the immunomodulator, VGX-1027, in endotoxin-induced uveitis in Lewis rats.

Authors:  K Mangano; N Y Sardesai; C Quattrocchi; E Mazzon; S Cuzzocrea; K Bendtzen; P L Meroni; J J Kim; F Nicoletti
Journal:  Br J Pharmacol       Date:  2008-09-08       Impact factor: 8.739

9.  Antigen-specific tolerance inhibits autoimmune uveitis in pre-sensitized animals by deletion and CD4+CD25+ T-regulatory cells.

Authors:  Bharati Matta; Purushottam Jha; Puran S Bora; Nalini S Bora
Journal:  Immunol Cell Biol       Date:  2009-11-03       Impact factor: 5.126

Review 10.  The role of complement in ocular pathology.

Authors:  Nalini S Bora; Purushottam Jha; Puran S Bora
Journal:  Semin Immunopathol       Date:  2008-02-26       Impact factor: 9.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.